The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,774.50
Bid: 1,774.00
Ask: 1,774.50
Change: -3.50 (-0.20%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,793.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

2 Jan 2024 15:00

RNS Number : 3767Y
GSK PLC
02 January 2024

GSK plc

Total Voting Rights and Capital

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following:

The Company's issued share capital as at 31 December 2023 consisted of 4,312,145,983 shares of 31 ΒΌ pence each ('Ordinary Shares'), of which 197,068,169 Ordinary Shares were held in Treasury.

Therefore, the total number of voting rights in the Company is 4,115,077,814. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Notifications may be sent to company.secretary@gsk.com.

V A Whyte

Company Secretary

2 January 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVRBBGDBSXGDGSD
Date   Source Headline
14th Apr 20212:14 pmRNSDirector/PDMR Shareholding
14th Apr 202111:58 amRNSDirector/PDMR Shareholding
12th Apr 20215:32 pmRNSDirector/PDMR Shareholding
12th Apr 20219:48 amRNSDirector/PDMR Shareholding
9th Apr 20215:34 pmRNSDirector/PDMR Shareholding
9th Apr 20211:35 pmRNSDirector/PDMR Shareholding
6th Apr 20212:30 pmRNSDirectorate Change
1st Apr 20213:36 pmRNSTotal Voting Rights
30th Mar 20214:21 pmRNSPublication of 2021 AGM Notice
30th Mar 202111:30 amRNSGSK respiratory product sales reporting changes
24th Mar 202112:30 pmRNSMoncef Slaoui Departs Galvani Bioelectronics
23rd Mar 20214:31 pmRNSDirector/PDMR Shareholding
17th Mar 20216:24 pmRNSChair of Audit & Risk Committee
16th Mar 202111:08 amRNSMedicago and GSK start Phase 3 trial
15th Mar 20215:27 pmRNSDirector/PDMR Shareholding
15th Mar 20217:00 amRNSAnnual Report 2020 on Form 20-F
11th Mar 20212:25 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSGSK and Vir share positive VIR-7831 data in COVID
10th Mar 20211:23 pmRNSDirector/PDMR Shareholding
9th Mar 20211:43 pmRNSAnnual Financial Report
2nd Mar 20213:48 pmRNSDirector/PDMR Shareholding
1st Mar 202110:55 amRNSTotal Voting Rights
25th Feb 202112:00 pmRNSGSK announces otilimab data for treatment of COVID
24th Feb 20211:59 pmRNSDirector/PDMR Shareholding
24th Feb 202112:13 pmRNSHolding(s) in Company
23rd Feb 20219:03 amRNSDirector/PDMR Shareholding
22nd Feb 20214:39 pmRNSDirector/PDMR Shareholding
22nd Feb 202110:40 amRNSSanofi and GSK initiate new Phase 2 study
19th Feb 202112:52 pmRNSDirector/PDMR Shareholding
19th Feb 202112:31 pmRNSDirector/PDMR Shareholding
19th Feb 202110:32 amRNSDirector/PDMR Shareholding
18th Feb 20219:59 amRNSDirector/PDMR Shareholding
17th Feb 202112:00 pmRNSGSK/Vir collaborate on antibodies for influenza
17th Feb 20219:00 amRNSDirector/PDMR Shareholding
15th Feb 202110:09 amRNSDirector/PDMR Shareholding
15th Feb 20219:15 amRNSDirector/PDMR Shareholding
12th Feb 20214:26 pmRNSDirector/PDMR Shareholding
12th Feb 20214:23 pmRNSDirector/PDMR Shareholding
12th Feb 20214:20 pmRNSDirector/PDMR Shareholding
10th Feb 20215:05 pmRNSDirector/PDMR Shareholding
10th Feb 20214:54 pmRNSDirector/PDMR Shareholding
4th Feb 202111:15 amRNSDirector/PDMR Shareholding
3rd Feb 202112:00 pmRNSFinal Results
3rd Feb 20217:00 amRNSGSK/CureVac partner on new mRNA Covid-19 vaccines
1st Feb 20212:04 pmRNSTotal Voting Rights
26th Jan 20214:26 pmRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSFDA approves ViiV Healthcare’s Cabenuva for HIV
20th Jan 20214:00 pmRNSDirector/PDMR Shareholding
20th Jan 20213:50 pmRNSDirector/PDMR Shareholding
20th Jan 20213:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.